Uawithya E, Kulchutisin K, Jitprapaikulsan J, Leelakanok N, et al. Safety and efficacy of programmed cell death-1 inhibitors in relapsed immune-privileged site lymphoma: A systematic review and meta-analysis. PLoS One 2025;20:e0319714.
PMID: 40299829